CAPRELSA (AstraZeneca Pharmaceuticals LP)
Welcome to the PulseAid listing for the CAPRELSA drug offered from AstraZeneca Pharmaceuticals LP. This Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | AstraZeneca Pharmaceuticals LP |
NON-PROPRIETARY NAME: | Vandetanib |
SUBSTANCE NAME: | VANDETANIB |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2011-07-25 |
END MARKETING DATE: | 0000-00-00 |
CAPRELSA HUMAN PRESCRIPTION DRUG Details:
Item Description | CAPRELSA from AstraZeneca Pharmaceuticals LP |
LABELER NAME: | AstraZeneca Pharmaceuticals LP |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/1) |
START MARKETING DATE: | 2011-07-25 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0310-7820_93695e2a-3d45-452d-aa6e-1e14181e56fa |
PRODUCT NDC: | 0310-7820 |
APPLICATION NUMBER: | NDA022405 |
Other VANDETANIB Pharmaceutical Manufacturers / Labelers: